Stock Track | Neogen Corp Plummets 5% as Q3 Earnings Miss Expectations and Losses Widen

Stock Track
11 Apr

Shares of Neogen Corp (NASDAQ:NEOG) plummeted 5.06% in Friday's trading session following the release of disappointing third-quarter results for fiscal year 2025. The food and animal safety products company reported widening losses and a revenue decline, falling short of analyst expectations and intensifying investor concerns about the company's financial health.

Neogen's Q3 2025 results painted a grim picture, with revenue dropping 3.4% year-over-year to $221.0 million, missing analyst estimates by 1.5%. The company's net loss expanded dramatically to $11.0 million, a 442% increase from the same quarter last year. Earnings per share deteriorated to a loss of $0.05, compared to a $0.009 loss in Q3 2024, and missed analyst forecasts by 200%. This poor performance has raised questions about Neogen's ability to navigate current market challenges and return to profitability.

The latest earnings miss adds to a prolonged period of struggle for Neogen's stock. Over the past five years, NEOG shares have lost a staggering 83% of their value, with a 57% decline in the last year alone. The company's transition to a loss-making position has made it difficult for investors to gauge its true value, leading to increased selling pressure. With the stock down 31% in the past week, including today's plunge, investors appear to be losing confidence in Neogen's turnaround prospects, despite recent insider buying activity that typically signals management's belief in the company's future.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10